Transformation of cell cultures as a parameter for detecting the potential carcinogenicity of antischistosomal drugs

Insights

Antischistosomal drugs and their metabolites can transform virus-infected rat cells, causing tumors in rats. Early cell culture screening is vital for developmental drug safety assessment.

Area of Science:

  • Toxicology
  • Oncology
  • Virology

Background:

  • Persistent viral infections, such as Rauscher leukemia virus, can alter cellular behavior.
  • Drug development requires rigorous safety testing to identify potential carcinogens.
  • Cell culture systems offer a model for studying viral-induced cell transformation.

Purpose of the Study:

  • To investigate the potential of antischistosomal drugs and their metabolites to induce cell transformation.
  • To evaluate the tumorigenicity of drug-transformed cells in vivo.
  • To highlight the utility of cell culture for early drug screening.

Main Methods:

  • Rat embryo cell cultures were persistently infected with Rauscher leukemia virus.
  • Infection-permissive cell cultures were treated with antischistosomal drugs and their metabolites.
  • Transformed cells were implanted into newborn rats to assess tumorigenicity and invasiveness.

Main Results:

  • Several antischistosomal drugs and their metabolites induced persistent transformation in virus-infected rat cell cultures.
  • Transformed cells, upon implantation into rats, produced fibrosarcomas.
  • Neither the virus nor the chemicals alone caused cell transformation or invasiveness.

Conclusions:

  • Antischistosomal drugs and their metabolites can act as potent oncogenic agents in the context of viral infection.
  • Cell culture systems provide a valuable platform for the early detection of drug-induced oncogenesis.
  • This study underscores the importance of comprehensive safety evaluations during drug development, particularly for compounds targeting infectious diseases.

Related Concept Videos